Company
Home
About Us
Message from the CEO
Leadership Team
News
Statistics
Incidence of Medical Errors
Corporate Responsibility
Quality Compliance
Terms of Use
Syringes
Safe-T-Syringe
®
OTC Dose-2-Weight Syringe – Pediatrics
Rx-Dose-2-Weight Syringe – Pediatrics
Diluent-2-Dose™
Vi-Syringe™
Drug Injections Kits
Calibrated Drug Delivery™
Pedia-Dose
®
Safe-T-Dose
®
Vi-Injection Kit™
Self Injection
Momenta-Dose™ Overview
Momenta-Dose™ PFS
Infusion Devices
Safe-T-Fuse™
Safe-T-Fuse™ Home Therapy
Safe-2-Dose® Containers
Inquiries
Contact Us
Sales Inquiries
Partnering with Asepsis
Leadership Team
asepsismedical
>
Leadership Team
Recent News
Asepsis Announces the Safe-2-Dose™ Integrated Dosing Container
Asepsis Announces Australian Patent Acceptance No. 2018232988 for its Multi-Indicia Infants’ and Children’s Oral Medication Dosing Applicator Comprising a Medication Paired Keyed End.
Asepsis announces the USPTO Notice of Allowance for its second Patent Application for the Safe-T-Fuse™ specialty drug infusion system.
Asepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349 encompassing the prefilled and ready to fill, Diluent-2-Dose™ syringe.
Asepsis Announces the Grant of Canada Patent Application CA2937327 for the Momenta-Dose™ – Force Actuated Injection.
Tweets by PedNursing
Menu
Company
Home
About Us
Message from the CEO
Leadership Team
News
Statistics
Incidence of Medical Errors
Corporate Responsibility
Quality Compliance
Terms of Use
Syringes
Safe-T-Syringe
®
OTC Dose-2-Weight Syringe – Pediatrics
Rx-Dose-2-Weight Syringe – Pediatrics
Diluent-2-Dose™
Vi-Syringe™
Drug Injections Kits
Calibrated Drug Delivery™
Pedia-Dose
®
Safe-T-Dose
®
Vi-Injection Kit™
Self Injection
Momenta-Dose™ Overview
Momenta-Dose™ PFS
Infusion Devices
Safe-T-Fuse™
Safe-T-Fuse™ Home Therapy
Safe-2-Dose® Containers
Inquiries
Contact Us
Sales Inquiries
Partnering with Asepsis
